359 related articles for article (PubMed ID: 14558094)
1. Neuronal and astrocytic damage in systemic lupus erythematosus patients with central nervous system involvement.
Trysberg E; Nylen K; Rosengren LE; Tarkowski A
Arthritis Rheum; 2003 Oct; 48(10):2881-7. PubMed ID: 14558094
[TBL] [Abstract][Full Text] [Related]
2. Relationship between elevated cerebrospinal fluid levels of plasminogen activator inhibitor 1 and neuronal destruction in patients with neuropsychiatric systemic lupus erythematosus.
Kwieciński J; Kłak M; Trysberg E; Blennow K; Tarkowski A; Jin T
Arthritis Rheum; 2009 Jul; 60(7):2094-101. PubMed ID: 19565516
[TBL] [Abstract][Full Text] [Related]
3. Intrathecal levels of matrix metalloproteinases in systemic lupus erythematosus with central nervous system engagement.
Trysberg E; Blennow K; Zachrisson O; Tarkowski A
Arthritis Res Ther; 2004; 6(6):R551-6. PubMed ID: 15535833
[TBL] [Abstract][Full Text] [Related]
4. Increased cerebrospinal fluid levels of neurofilament protein in progressive supranuclear palsy and multiple-system atrophy compared with Parkinson's disease.
Holmberg B; Rosengren L; Karlsson JE; Johnels B
Mov Disord; 1998 Jan; 13(1):70-7. PubMed ID: 9452329
[TBL] [Abstract][Full Text] [Related]
5. Elevated levels of soluble fractalkine in active systemic lupus erythematosus: potential involvement in neuropsychiatric manifestations.
Yajima N; Kasama T; Isozaki T; Odai T; Matsunawa M; Negishi M; Ide H; Kameoka Y; Hirohata S; Adachi M
Arthritis Rheum; 2005 Jun; 52(6):1670-5. PubMed ID: 15934075
[TBL] [Abstract][Full Text] [Related]
6. Intrathecal cytokines in systemic lupus erythematosus with central nervous system involvement.
Trysberg E; Carlsten H; Tarkowski A
Lupus; 2000; 9(7):498-503. PubMed ID: 11035414
[TBL] [Abstract][Full Text] [Related]
7. Increased serum matrix metalloproteinase 9 levels in systemic lupus erythematosus patients with neuropsychiatric manifestations and brain magnetic resonance imaging abnormalities.
Ainiala H; Hietaharju A; Dastidar P; Loukkola J; Lehtimäki T; Peltola J; Korpela M; Heinonen T; Nikkari ST
Arthritis Rheum; 2004 Mar; 50(3):858-65. PubMed ID: 15022328
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic reliability of cerebral spinal fluid tests for acute confusional state (delirium) in patients with systemic lupus erythematosus: interleukin 6 (IL-6), IL-8, interferon-alpha, IgG index, and Q-albumin.
Katsumata Y; Harigai M; Kawaguchi Y; Fukasawa C; Soejima M; Takagi K; Tanaka M; Ichida H; Tochimoto A; Kanno T; Nishimura K; Kamatani N; Hara M
J Rheumatol; 2007 Oct; 34(10):2010-7. PubMed ID: 17896804
[TBL] [Abstract][Full Text] [Related]
9. Antiribosomal P protein antibodies in cerebrospinal fluid are associated with neuropsychiatric systemic lupus erythematosus.
Yoshio T; Hirata D; Onda K; Nara H; Minota S
J Rheumatol; 2005 Jan; 32(1):34-9. PubMed ID: 15630721
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-6 and chemokines in the neuropsychiatric manifestations of systemic lupus erythematosus.
Fragoso-Loyo H; Richaud-Patin Y; Orozco-Narváez A; Dávila-Maldonado L; Atisha-Fregoso Y; Llorente L; Sánchez-Guerrero J
Arthritis Rheum; 2007 Apr; 56(4):1242-50. PubMed ID: 17393453
[TBL] [Abstract][Full Text] [Related]
11. Neurochemical markers of brain damage in cerebrospinal fluid during induction treatment of acute lymphoblastic leukemia in children.
Osterlundh G; Kjellmer I; Lannering B; Rosengren L; Nilsson UA; Márky I
Pediatr Blood Cancer; 2008 Apr; 50(4):793-8. PubMed ID: 17973312
[TBL] [Abstract][Full Text] [Related]
12. Clinical analysis of cerebrospinal fluid interleukin-6 in neuropsychiatric systemic lupus erythematosus.
Horai Y; Watanabe H; Miyamura T; Takahama S; Hirata A; Nakamura M; Ando H; Minami R; Yamamoto M; Suematsu E
Fukuoka Igaku Zasshi; 2010 Feb; 101(2):34-40. PubMed ID: 20560477
[TBL] [Abstract][Full Text] [Related]
13. Diffusion changes in patients with systemic lupus erythematosus.
Zhang L; Harrison M; Heier LA; Zimmerman RD; Ravdin L; Lockshin M; Uluğ AM
Magn Reson Imaging; 2007 Apr; 25(3):399-405. PubMed ID: 17371731
[TBL] [Abstract][Full Text] [Related]
14. Differential roles of the anti-ribosomal P antibody and antineuronal antibody in the pathogenesis of central nervous system involvement in systemic lupus erythematosus.
Isshi K; Hirohata S
Arthritis Rheum; 1998 Oct; 41(10):1819-27. PubMed ID: 9778223
[TBL] [Abstract][Full Text] [Related]
15. Kinins and cytokines in plasma and cerebrospinal fluid of patients with neuropsychiatric lupus.
Dellalibera-Joviliano R; Dos Reis ML; Cunha Fde Q; Donadi EA
J Rheumatol; 2003 Mar; 30(3):485-92. PubMed ID: 12610806
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid neurofilament and glial fibrillary acidic protein in patients with cerebral vasculitis.
Nylén K; Karlsson JE; Blomstrand C; Tarkowski A; Trysberg E; Rosengren LE
J Neurosci Res; 2002 Mar; 67(6):844-51. PubMed ID: 11891800
[TBL] [Abstract][Full Text] [Related]
17. Flow cytometric assessment of anti-neuronal antibodies in central nervous system involvement of systemic lupus erythematosus and other autoimmune diseases.
Kang EH; Shen GQ; Morris R; Metzger A; Lee EY; Lee YJ; Lee EB; Song YW
Lupus; 2008 Jan; 17(1):21-5. PubMed ID: 18089679
[TBL] [Abstract][Full Text] [Related]
18. Cerebral MRI abnormalities and their association with neuropsychiatric manifestations in SLE: a population-based study.
Ainiala H; Dastidar P; Loukkola J; Lehtimäki T; Korpela M; Peltola J; Hietaharju A
Scand J Rheumatol; 2005; 34(5):376-82. PubMed ID: 16234185
[TBL] [Abstract][Full Text] [Related]
19. Astrocytic damage is far more severe than demyelination in NMO: a clinical CSF biomarker study.
Takano R; Misu T; Takahashi T; Sato S; Fujihara K; Itoyama Y
Neurology; 2010 Jul; 75(3):208-16. PubMed ID: 20644148
[TBL] [Abstract][Full Text] [Related]
20. MRI findings in central nervous system systemic lupus erythematosus are associated with immunoserological parameters and hypertension.
Csépány T; Bereczki D; Kollár J; Sikula J; Kiss E; Csiba L
J Neurol; 2003 Nov; 250(11):1348-54. PubMed ID: 14648152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
